Pricing
  1. JP-listed companies
  2. M3, Inc.
  3. Financials
  4. Revenue

M3, Inc. (2413)

Market cap
¥1.1T
P/E ratio
24.5x
M3 transforms healthcare through digital platforms, connecting doctors, patients, and medical institutions with services ranging from clinical trials to career support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 2025284,900+19.26%
Mar 31, 2024238,883+3.49%
Mar 31, 2023230,818+10.89%
Mar 31, 2022208,159+23.03%
Mar 31, 2021169,198+29.19%
Mar 31, 2020130,973+15.84%
Mar 31, 2019113,059+19.68%
Mar 31, 201894,471+20.90%
Mar 31, 201778,143+20.85%
Mar 31, 201664,660+25.86%
Mar 31, 201551,376+39.28%
Mar 31, 201436,887+41.83%
Mar 31, 201326,008+36.59%
Mar 31, 201219,041

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat